CD274 and cancer: However, these events offer cancer cells a window of opportunity to evade future killing through various mechanisms, including immunoediting and loss of antigen expression [9], downregulation of MHC-I [110], production of immune-suppressive substances and ligands (such as adenosine, PD-L1, or cancer-derived extracellular vesicles) [111–113], among others.